牧原股份(02714)1月29日至2月3日招股 预计2月6日上市

Core Viewpoint - The company, Muyuan Foods, is set to launch an IPO from January 29 to February 3, 2026, aiming to issue 274 million shares globally, with a maximum price of HKD 39.00 per share [1] Group 1: Company Overview - Muyuan Foods is a technology-driven leader in the pork industry, recognized as a pioneer in smart pig farming with over 30 years of experience [2] - The company operates a vertically integrated business model covering the entire pork production chain, including breeding, farming, feed production, and slaughtering [2] - According to Frost & Sullivan, Muyuan Foods is the largest pig farming enterprise globally by production capacity and output since 2021, maintaining the highest output for four consecutive years [2] Group 2: Market Position and Growth - The company's global market share in pig output increased from 2.6% in 2021 to 5.6% in 2024, surpassing the combined market share of the second to fourth largest competitors [2] - Muyuan Foods entered the slaughtering and meat processing business in 2019 to enhance its operational advantages across the entire industry chain [2] - By 2024, the company is projected to rank fifth globally and first in China in terms of slaughtering and meat processing by headcount, with the highest revenue CAGR among large Chinese competitors from 2021 to 2024 [2] Group 3: Financial Performance - From 2014 to 2024, the company's total revenue CAGR reached 48.7%, the highest among the top ten publicly listed pork companies globally by output [3] - The net profit CAGR during the same period was 72.7%, with an average net profit margin of 19.0%, making it the only company among the top ten to maintain a net profit margin above 15% [3] - The company's EBITDA CAGR from 2014 to 2024 was 60.2%, with an average EBITDA margin of 30.8%, outperforming other large listed companies in the Chinese pig farming industry [3] Group 4: IPO and Fund Utilization - The company has signed cornerstone investment agreements with several major investors, agreeing to subscribe for shares worth approximately HKD 5.342 billion, contingent on certain conditions [4] - Assuming the maximum share price of HKD 39.0, the estimated net proceeds from the global offering will be approximately HKD 10.46 billion, potentially increasing to HKD 12.038 billion if the over-allotment option is fully exercised [4] - Approximately 60% of the net proceeds will be used to explore overseas opportunities, 30% for R&D to drive technological innovation across the industry chain, and 10% for working capital and general corporate purposes [4]